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ABSTRACT
The metabolic SearcH And Reconstruction Kit
(metaSHARK)isanewfullyautomatedsoftwarepack-
age for the detection of enzyme-encoding genes
within unannotated genome data and their visualiza-
tion in the context of the surrounding metabolic net-
work.Thegenedetectionpackage (SHARKhunt)runs
on a Linux system and requires only a set of raw DNA
sequences (genomic, expressed sequence tag and/
or genome survey sequence) as input. Its output
may be uploaded to our web-based visualization
tool (SHARKview) for exploring and comparing data
from different organisms. We first demonstrate the
utility of the software by comparing its results for
the raw Plasmodium falciparum genome with the
manual annotations available at the PlasmoDB and
PlasmoCyc websites. We then apply SHARKhunt to
the unannotated genome sequences of the coccidian
parasite Eimeria tenella and observe that, at an
E-value cut-off of 10
 20, our software makes 142
additional assertions of enzymatic function com-
pared with a recent annotation package working
with translated open reading frame sequences. The
ability of the software to cope with low levels of
sequence coverage is investigated by analyzing
assemblies of the E.tenella genome at estimated
coverages from 0.5· to 7.5·. Lastly, as an example
of how metaSHARK can be used to evaluate the
genomic evidence for specific metabolic pathways,
we present a study of coenzyme A biosynthesis in
P.falciparum and E.tenella.
INTRODUCTION
The genomics revolution continues to produce biological
sequence data at an ever-increasing rate. At the time of writ-
ing, the GOLD database (http://www.genomesonline.org) lists
233 published and 1000 ongoing genome projects. However,
the completion of genome sequencing only marks the begin-
ning of a long and difﬁcult process of deriving biological
knowledge from these data. The huge task of ‘genome annota-
tion’ includes both the identiﬁcation of the set of coding
regions in the genomic DNA and the assignment of function
to those genes.
While there exist many computer packages to aid in this
work, the complete annotation of a genome still requires a
tremendous amount of effort from a dedicated team of pro-
fessionals, and hence a very large investment of time and
money. The sheer number of ongoing genome projects and
theirrangeofscalesandbudgetsindicate thatthereisanurgent
need for fully automated tools, both to generate preliminary
annotations and to derive new knowledge as the genome
sequencingiscompleted. Organismsthatmight beneﬁt include
numerous fungi of environmental, agricultural and medical
importance, parasites of medical and veterinary importance
in developing countries, such as trypanosomes and worms,and
members of the kingdom Stramenopiles (or Chromista),
including diatoms and important plant pathogens.
One such use of genome data is in the preparation of a
preliminary annotation of enzyme-encoding genes, and
hence the elucidation of the network of reactions they catalyse
within an organism (1,2). Differences in metabolism between
host and pathogen species may highlight novel drug targets
to feed into the drug development pipeline (3). New methods
for the qualitative analysis of metabolic networks, such as
elementary mode analysis (4) or the closely related extreme
pathway analysis (5), can reveal novel pathways and hence
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doi:10.1093/nar/gki285new insights into metabolic diseases. Enzyme annotation is a
good candidate for automation owing to the large amount of
knowledge that has been assembled in metabolic databases,
such as KEGG (6), BioCyc (7) and BRENDA (8). These
databases include references to protein sequence data from
known enzymes in a wide variety of organisms, which can
be used as models in searches of newly sequenced genomes.
Existing semi-automated enzyme annotation software
(2,9–11) starts with a set of predicted proteins from an annot-
ated genome and, by a variety of text mining and/or sequence
comparison methods, constructs a list of the enzymatic
functions that are asserted to be present. Our software
(SHARKhunt) differs in that it requires only a set of DNA
sequences [ﬁnished chromosomes, contigs, genome survey
sequences or expressed sequence tags (ESTs)] as input, and
hence can be applied to extract new knowledge of metabolic
capabilities from preliminary data produced by unannotated
and ongoing genome sequencing projects. Models derived
from sets of known enzymes are used to search through the
DNA sequences to ﬁnd regions with signiﬁcant similarity to
the model sequences. The conﬁdence of each functional
assertion is measured by an E-value score, and the full set
of predictions is output in various formats for consultation,
human curation orfurther automated network analysis.Results
may be uploaded to an online visualization tool (SHARK-
view), which permits users to browse freely around the
KEGG metabolic network, run BLAST (12) searches on
their predicted gene sequences and compare data from differ-
ent organisms or different sources of annotation.
MATERIALS AND METHODS
Preparation of data
The SHARKhunt search protocol described below requires
both a set of PSI-BLAST (12) polypeptide proﬁles and a
set of associated HMMER proﬁle hidden Markov models
(HMMs) (13). We use the set of PRIAM PSI-BLAST proﬁles
(11) (July 2004 version) and the protein sequence data from
which they were derived as the basis for our proﬁle HMMs.
This set constitutes 2562 PSI-BLAST proﬁles covering a total
of 1967 enzymatic functions, deﬁned by Enzyme Commission
(EC) number. There are more proﬁles than functions in the
PRIAM data because some functions are represented by more
than one homologous family of proteins. For each PRIAM
proﬁle containing more than one sequence, a HMM is gener-
atedbytakingtheoriginalsetofproteinsequencesconstituting
the proﬁle, constructing a multiple alignment using MUSCLE
(14) and passing this to the HMMbuild program (part of the
HMMER package, available from http://hmmer.wustl.edu).
The SHARKhunt search protocol
The search method used in SHARKhunt is an automated ver-
sion of a protocol that we have previously demonstrated to be
effectiveinsearchinggenomicDNAfordistanthomologuesof
a set of model sequences (15). The Wise2 package (16) is used
to aligning the proﬁle HMMs with genomic DNA and produce
predicted polypeptide sequences for the resulting hypothetical
gene fragments. Although the Wise2 algorithm is very power-
ful, it is too slow to be used to search through a whole genome.
Hence, we apply a preliminary ﬁltering step, where
PSI-TBLASTN (12) is used to search the genome for
regions with some similarity to each original PRIAM proﬁle
(hits with E-value < 1.0). These regions are then extracted
from the genome and passed to Wise2 for further analysis
with the appropriate HMM (Figure 1). Any resulting Wise2
hits are assessed by using PSI-BLAST to compare the
predicted polypeptide translation with the original PRIAM
proﬁle, and the E-values and locations of predicted coding
regions are output.
In cases where several different proﬁles produce hits to the
same region of DNA, we take the function of that region to be
the same as the best hit (i.e. the lowest E-value). Some
enzymes require more than one functional unit in order to
operate, or are represented by more than one homologous
family of proteins. This has already been taken into account
in the generation of the PRIAM proﬁles and their associated
logical AND/OR rules (11). To assert the presence of an
enzymatic function in the genome, the hits must agree with
the relevant PRIAM rule.
The SHARKhunt package (including the programs MUS-
CLE, HMMer, PSI-BLAST and Wise2 and the necessary
PRIAM proﬁle data) is available to download from the meta-
bolic SearcH And Reconstruction Kit (metaSHARK) website
(http://bioinformatics.leeds.ac.uk/shark/). The package com-
prises two executable scripts:
(i) SHARKhunt invokes a Java program to run the profile
searches. The output files created by this program include
a FASTA format library of predicted polypeptide
sequences, a GFF (gene feature format, see http://
www.sanger.ac.uk/Software/formats/GFF/) file contain-
ing the locations of the predicted gene structures on the
DNA sequence, a list of EC numbers representing the
functions detected within the input DNA, together with
their PSI-BLAST E-value confidence scores, and an
eXtensible Markup Language (XML) file, which may
be uploaded to the metaSHARK website (see above
URL) for easy browsing and visualization of the results.
(ii) SHARKmodel allows users to create their own PSI-
BLAST and HMMer profile models from sets of homo-
logous polypeptide sequences for customized searches
using the SHARKhunt protocol.
Verification of search method
To conﬁrm that the search protocol is effective in detecting
enzyme-encoding genes within eukaryotic DNA, SHARKhunt
was run on the genome of the human malaria parasite,
Plasmodium falciparum (17). The proﬁle data used for this
search were a special ‘jacknife’ dataset, prepared from the
original PRIAM models by removing all sequences from
Plasmodium spp. and re-making the affected proﬁles (38
out of 2562 proﬁles).
The results were compared with the enzymatic functions
annotated for this organism in the initial genome publication
(17) (data available at the PlasmoDB website: http://
www.plasmodb.org/) and the subsequent re-annotation of
metabolic enzymes prepared by the PlasmoCyc team (18)
(http://plasmocyc.stanford.edu/).
As a comparison with an existing method based on
polypeptide sequence input, searches were also run against
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set of jacknife PSI-BLAST proﬁles and all predicted poly-
peptides from the original genome annotation.
Analysis of preliminary genome sequences
As a practical example of how metaSHARK may be used to
investigate metabolic pathways within unﬁnished genomes,
we applied the software to the available genomic DNA
sequences of another apicomplexan parasite, the coccidian
Eimeriatenella(http://www.sanger.ac.uk/Projects/E_tenella/).
A full description of the E.tenella genome project has
been given elsewhere (19). Brieﬂy, more than 855000
reads with an average read length of 525 bp have yielded
 45 Mb of unique sequence for a coverage of  7.5·. The
data are presently assembled into 8718 contigs and the G+C
content of the genome is  53%. Little annotation has yet been
undertaken on this genome, and ab initio geneﬁnding is ham-
pered by the current lack of well-characterized gene structures
in Eimeria spp. As such, it presents us with a good example
of an organism for which the metaSHARK system may be
of use.
For comparison with SHARKhunt, we ran the PRIAM soft-
ware on all E.tenella open reading frames (ORFs) of 50 amino
acids or longer. In addition, the best available ab initio gene
predictions for this species were obtained using the geneﬁnd-
ing program TwinScan2 (20), trained on a set of 350 human-
annotated genes from the related coccidian, Toxoplasma
gondii (Aaron J. Mackey, personal communication). The
polypeptide translations of these gene predictions were used
in a PRIAM analysis, in parallel with the genomic ORF data.
The PRIAM software was also run on all ORFs of at least
50 amino acids found within the clustered (98% similarity)
EST+ORESTES data available for E.tenella (downloadable
from the Sanger Institute website, see http://www.sanger.
ac.uk/Projects/E_tenella/). These clusters were obtained by
using publicly available ESTs from the NCBI and open read-
ing frame-expressed sequence tags (ORESTES) cDNA reads
generated by Alda M. Madeira and Arthur Gruber at the Uni-
versity of Sao Paulo, Brazil (unpublished data). ORESTES
reads are cDNA fragments synthesized by a low stringency
RT–PCR process using arbitrary 18–25mer primers (21).
Effect of variation in genome coverage on performance
To investigate how the number of enzymatic functions pre-
dicted bySHARKhuntisaffectedbyvariationsinthe coverage
of the input genome sequence, we re-ran the E.tenella searches
using an earlier genome assembly based on an  4.3· genome
coverage (from December 2002), and also on an assembly
constructed using the program Phrap (http://www.phrap.org/)
from sets of reads representing  0.5· coverage (all data
obtained from the Sanger Institute website).
RESULTS AND DISCUSSION
Verification of search method
Owing to its high A+T content and phylogenetic distance from
any well-studied model species, it is particularly difﬁcult to
establish a gold standard for the full set of enzymes encoded
by P.falciparum. However, there has been a substantial recent
effort by Yeh et al. (18) working on the PlasmoCyc project to
catalogue the enzymatic reactions believed to operate in this
parasite, and to provide an extensive re-annotation of the gen-
ome sequence to identify as many of the enzymes implicated
Figure 1. The SHARKhunt search protocol is a two-stage, profile-based method that aims at detecting all regions of a genome homologous to an enzyme model. A
preliminary PSI-TBLASTN search (12) identifies regions with some similarity to a PRIAM profile. These regions are extracted from the genome and passed to the
Wise2program(16)toattempta homology-basedgenestructureprediction.If Wise2detectssufficientsimilaritybetweenthemodelHMMandtheDNAregion,an
intron/exon structure will be predicted and the resulting polypeptide sequence output. This sequence is then aligned with the original PRIAM profile to obtain an
E-value score for each hit found.
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EC-labelled reactions within the PlasmoCyc database for
which a PRIAM proﬁle was available (henceforth referred
to as PlasmoCyc-RXN). Eliminating enzymes not contained
in PRIAM gives a fair test of the capabilities of both PRIAM
and SHARKhunt, since neither system is able to detect an
enzyme for which it has no model. It should be noted that
this standard set of EC numbers includes both the enzymes
annotated by PlasmoCyc (the set PlasmoCyc-ANN) and all
enzymatic functions that are assumed to be present based on
our current knowledge of Plasmodium biology, but that have
notyetbeenidentiﬁedwithinthegenome.Thischoiceofstand-
ard has been made so that predictions that are in agreement
with known biology are treated as true positive even if they
do not yet have gene annotations in PlasmoCyc. Although
this avoids unfairly penalizing the search methods tested, it
also means that a large number of false-negative predictions
are likely to be made, and hence that the sensitivity scores
quotedwillappearlowerthanisusual.Nevertheless,thechoice
of standard does allow a good comparison between the
search methods used and with the original genome annotation.
The numbers of true and false positives predicted by
SHARKhunt and PRIAM, working from the P.falciparum
genomicDNA sequence andannotatedpolypeptidesequences,
respectively, are shown in Table 1 for the three E-value cut-
offs 10
 30,1 0
 20 and 10
 10 (see Table legend for deﬁnitions
of true and false-positive predictions). These E-value scores
are calculated in the same way for both programs, by using
the PSI-BLAST software to measure similarity between a
polypeptide and a PRIAM proﬁle, and hence they offer a
directly comparable measure of performance. In addition, we
have included the corresponding numbers of true and false-
positive predictions derived from the original P.falciparum
manual annotation (17) (discarding EC numbers not found
in PRIAM—we label this set PlasmoDB-ANN), as compared
with PlasmoCyc-RXN. The SHARKhunt program performs
almost as well in this comparison as the PRIAM automated
enzyme annotation software, which is working with the set of
annotated polypeptides taken from PlasmoDB. This indicates
that the presence of introns in many P.falciparum genes does
not adversely affect the SHARKhunt predictions made for
this genome. Both programs make approximately the same
numbers of predictions at the three E-value cut-offs taken,
although the speciﬁcity is slightly higher for PRIAM
than SHARKhunt at more relaxed cut-offs (2% higher
for E-value < 10
 10). At an E-value cut-off of 10
 10, both
programs are able to detect signiﬁcant numbers of true
positives that were missed in the original human annotation,
achieving  54% sensitivity as compared with  46% for
PlasmoDB-ANN.
This test demonstrates that our software can detect
enzyme-encoding genes with an accuracy equivalent to that
ofPRIAM,butwith theadvantage thatitmaybeapplied toany
genome, regardless of whether a reliable set of predicted poly-
peptides is available. PRIAM runs many times faster than
SHARKhunt (just over 1 h on a 1.8 GHz Linux node for
this genome, compared with over 100 h for SHARKhunt on
the same machine), but requires a good annotation of gene
structures to produce reliable results.
Analysis of preliminary genome sequences
The coccidian parasite E.tenella is known to have large num-
bers of introns in its genes. This can make homology searches
difﬁcult in the absence of an annotated genome: protein versus
DNA searches, such as TBLASTN (12), may fail owing to
sizeable breaks in coding DNA, and protein versus protein
searches [e.g. BLASTP (12)] applied to ORFs may also give
disappointing results, since a gene with several introns may be
split over many short ORFs. These factors make the E.tenella
genome an interesting test case for SHARKhunt.
Since no annotation is available for this genome, we do not
have a standard against which to compare the search results
and so cannot obtain reliable numbers of true- and false-
positive predictions. We can, however, compare the predic-
tions made by PRIAM from the sets of genomic ORFs and ab
initio gene predictions with the SHARKhunt results from the
analysisofthe genomicDNAsequences, under the assumption
that the false-positive rate will remain relatively similar to that
measured in the P.falciparum analysis for both programs. The
enzymatic functions asserted by each of these three methods at
an E-value cut-off of 10
 20 are shown in the form of a Venn
diagram in Figure 2. PRIAM predicted 177 functions from
the ab initio genes and 160 from the ORF data, whereas
Table 1. Performance of SHARKhunt and PRIAM for P.falciparum, at varying E-value cut-offs
E-value cut-off Total predictions TP FP FN Sensitivity (%) Specificity (%)
SHARKhunt (on genomic DNA) 10
 30 235 198 37 265 42.8 84.3
10
 20 273 223 50 240 48.2 81.7
10
 10 333 247 86 216 53.3 74.2
PRIAM (on annotated polypeptides) 10
 30 229 193 36 270 41.7 84.3
10
 20 269 222 47 241 47.9 82.5
10
 10 328 250 78 213 54.0 76.2
PlasmoDB-ANN (original human annotation) n/a 232 214 18 249 46.2 92.2
PlasmoCyc-ANN (human reannotation) n/a 304 304 n/a 159 65.7 n/a
Note: PlasmoDB-ANN, the set of EC numbers assigned in the original P.falciparum genome annotation (17) for which PRIAM (11) profiles were available;
PlasmoCyc-RXN,the set ofall EC-labelledreactionswithinthe PlasmoCycdatabase(18) forwhich a PRIAMprofilewas available; PlasmoCyc-ANN, the subsetof
PlasmoCyc-RXNforwhichenzymeshavebeenannotatedbyPlasmoCyccurators;TP,numberoftruepositives(predictionsthatwerealsocontainedinPlasmoCyc-
RXN); FP, number of false positives (predictions that were not in PlasmoCyc-RXN); and FN, number of false negatives (PlasmoCyc-RXN functions that were not
detected).
We calculate specificity as TP/(TP + FP) · 100% and sensitivity as TP/(TP + FN) · 100%. The corresponding values for the original P.falciparum annotation
(PlasmoDB-ANN) (17) and the PlasmoCyc-ANN reannotation (18) are included for comparison.
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majority (89%) of PRIAM predictions and including an addi-
tional 102 that were not detected by PRIAM in either poly-
peptide dataset derived from the genomic DNA. It is notable
that the ab initio gene predictions made using T.gondii training
data were only slightly more informative for enzymatic
function than the set of ORFs of length 50 amino acids or
more, demonstrating that geneﬁnding software trained on a
species related to the target genome may not always produce a
comprehensive set of predictions.
Figure 3 compares the predictions made by PRIAM from
the EST+ORESTES ORFs with those made by PRIAM and
SHARKhunt based on the genomic data. All results here were
generated using an E-value cut-off of 10
 20. The relatively
low number of functional predictions made from the
EST+ORESTES ORFs (109 functions) is explained by the
fact that enzymes are generally expressed at very low levels
in the cell, so will be detected at a correspondingly low rate by
EST or ORESTES sequencing. However, the fact that almost
all (92%) of the functions predicted from these expression data
are also present in the SHARKhunt results for genomic DNA
shows that our software is successful in detecting E.tenella
genes, despite the large number of introns present. SHARK-
hunt detects considerably more of these EST+ORESTES-
derived functions within the genome than PRIAM does
(81 and 70% for the ab initio and ORF data, respectively).
Overall, these results demonstrate that the homology-based
geneﬁnding method used by SHARKhunt can be a much more
effective way to detect enzymatic functions within an unan-
notated genome with high intron number than existing meth-
ods based on the analysis ofpolypeptide sequences,even when
gene models from a related organism are available.
Effect of variation in genome coverage on performance
Since SHARKhunt is expected to be useful for the analysis
of preliminary genome sequence data, it is interesting to
investigate how performance is affected by low genome cov-
erage. Taking the SHARKhunt results (at an E-value cut-off of
Figure 2. ComparisonofassertedenzymaticfunctionsinE.tenellaobtainedby
runningPRIAMontheabinitiogenepredictionsgeneratedbyTwinScan2(20)
trainedonT.gondiigenemodelsandonallgenomicORFsover50aminoacids,
and by running SHARKhunt on the full set of genomic DNA contigs. An
E-value cut-off of 10
 20 was used for each method. Note that the SHARKhunt
analysis predicts 102 functions that were missed in both PRIAM analyses.
Figure3. BarchartshowingnumbersofpredictedenzymaticfunctionsinE.tenellaobtainedbySHARKhunt,byPRIAMrunonourabinitiogenepredictionsandby
PRIAMrunongenomicORFsofatleast50aminoacids.ThebartotheleftshowsthenumberoffunctionspredictedbyPRIAMrunonORFsofatleast50aminoacids
fromtheE.tenellaEST+ORESTESdata.Theproportionofthesefunctionsalsopredictedbyeachofthethreegenomicmethodsisshowninblackforeachmethod.An
E-value cut-off of 10
 20 was used for all searches.
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 20) for the current E.tenella assembly ( 7.5· coverage) as
the standard, we calculated the percentage of these functions
detected by SHARKhunt using an assembly at  4.3· gener-
ated in 2002 and using our own Phrap assembly of reads
totalling  0.5· coverage. These results are shown in Table 2.
It is notable that the reduction from  7.5· to  4.3· cov-
erage has very little effect on the predictions made by
SHARKhunt. With a further reduction to  0.5· coverage,
the program still detects over 40% of the enzymes found
using the  7.5· assembly. This implies that even very
small genome sequencing projects should have sufﬁcient
data to give a general picture of the metabolic capabilities
of an organism, and to support wet-lab experiments to search
for missing genes in known pathways.
Network visualization with SHARKview
In order to assist researchers in interpreting the results of a
genome search, we have constructed an online database of
known metabolic processes, visualized graphically as a net-
work upon which the SHARKhunt results may be projected.
A specialized database (SHARKdb) was developed using
the pure Java object-oriented database management system,
ozone (http://www.ozone-db.org), which is freely available
open source software. Our overall metabolic network was
imported to SHARKdb from the KEGG/LIGAND database
(6) (release 26), with corrected reaction equations (including
reversibility information and deﬁnitions of path and pool
metabolites, see legend to Figure 4 for deﬁnitions) derived
from the data of Ma and Zeng (22).
The generic metabolic network from KEGG is stored in the
database in the form of a Petri net (23). This is a mathematical
graph structure that is gaining popularity in the ﬁeld of bio-
logical network analysis (24). It is especially well suited to the
representation of metabolic networks, since reactions and the
enzymes that catalyse them are treated as separate objects,
allowing a single enzyme to catalyse several different reac-
tions(e.g. withalternativesubstrates),orasinglereaction tobe
catalysed by several different enzymes. Figure 4 shows a Petri
net representation of a simple enzymatic reaction. In addition
to its intuitive graphical representation, the Petri net structure
will make computational analysis of the metabolic networks
inferred from SHARKhunt results much more convenient in
future studies, e.g. in the computation of elementary ﬂux
modes representing metabolic pathways (4).
The metaSHARK package includes a novel network visu-
alization tool called SHARKview (Figure 5). This has been
developed from the TouchGraph dynamic graph layout library
(http://www.touchgraph.com) and runs as an applet in the
user’s web browser. The Petri net structure of the metabolic
network is clearly presented, with circular or elliptical nodes
(‘places’ in Petri net terminology) representing compounds,
and square nodes (‘transitions’) representing reactions. The
arrows (‘arcs’) linking compounds and reactions show the
consumption and production of metabolites during the reac-
tion. Enzymes are depicted as rounded rectangles, connected
to reactions by a different type of arc called a ‘test arc’. The
test arc indicates that, unlike a compound, an enzyme is not
consumed by the reactions in which it participates. Most re-
actions are reversible and can have their displayed direction
changed by the user, but those identiﬁed as irreversible by Ma
and Zeng (22) cannot be changed. An irreversible reaction is
shown with a diagonal white stripe across the reaction node.
The SHARKview applet permits users to browse the data-
base, starting from any compound, reaction, enzyme or pre-
deﬁned network (derived from the KEGG pathway diagrams).
A blue tag at the corner of a node indicates that it has more
neighbours in the database than are currently loaded by the
browser. These neighbours may be retrieved on demand in
order to build up user-deﬁned sub-networks and pathways, a
function not possible with the static KEGG pathway diagrams.
SHARKview initially displays only the generic network
structure stored in the database, but the results of a SHARK-
hunt search of a particular genome can also be uploaded and
superimposed on the metabolic network. To represent the
strength of the evidence for each enzyme, nodes are coloured
according to E-value, with cut-offs at 10
 20 and 10
 10. This
colour scheme helps the user to pick out the encoded path-
ways, and also makes it easier to spot potential ‘missing
enzymes’, where most of a pathway has strong evidence, but
one or more of the enzymes have not been detected by the
software or have only tentative assignments. The evidence for
each SHARKhunt prediction may be viewed in more depth
Table 2. Comparison of SHARKhunt performance for E.tenella at varying
levels of genome coverage
Genome
coverage
No. of functions
predicted at an
E-value cut-off of 10
 20
Percentage of
functions predicted
using  7.5· assembly
 7.5· 288 100
 4.3· 274 95
 0.5· 117 41
The  7.5· and  4.3· assemblies were obtained directly from the Sanger
Institute Eimeria project website (http://www.sanger.ac.uk/Projects/
E_tenella/). The  0.5· assembly was generated with Phrap (http://www.
phrap.org/) using a subset of the raw reads obtained from the same site.
Figure 4. A SHARKview Petri net representation of the reaction alpha-
D-glucose + ATP ! alpha-D-glucose-6-phosphate + ADP, catalysed by the
enzymehexokinase.Theorangeovalsrepresent‘path’metabolites,considered
to lie on metabolic pathways as source, intermediate or sink compounds. Blue
ovals represent ‘pool’ metabolites, such as water or ATP, which act as co-
factors for metabolic pathways but are not generally considered as intermedi-
ates.Reactionsareshownassquarenodeswithopen-headedarrows,indicating
theconsumptionandproductionofmetabolites.Enzymesareshownasrounded
rectangles, connected to the reactions they catalyse with full-headed arrows.
Petri net representations for biological pathways are reviewed in (24).
1404 Nucleic Acids Research, 2005, Vol. 33, No. 4on its own webpage, which provides direct links to the NCBI
BLAST server for further sequence analysis. Uploaded
data are stored in the user’s private workspace, which is pro-
tected by a password. This workspace may also be used to
store customized SHARKview network diagrams for later
retrieval.
Aswellasexaminingasinglemetabolicannotation,SHARK-
view can also visualize comparisons between the SHARKhunt
results for two different genomes. The user selects the two
genomes to be compared and an E-value cut-off above which
anenzymeassertionisignored.Colourcodingthenindicatesthe
enzymes found in each genome and those common to both
genomes. Careful use of this feature should make it easy to
detect differences in the metabolic capabilities of related spe-
cies, or to highlight potential drug targets where a pathogen
has an essential pathway that the host lacks.
To enable the metaSHARK system to be used with genome
annotation data from other sources (either from a manual
annotation or from a program, such as PRIAM), or alternat-
ively with data derived from microarray experiments, we have
also madeit possibletoupload asimple listofECnumbers and
visualizethemwiththeSHARKviewappletinthesamewayas
the SHARKhunt XML results. Users may choose to supply
extra information for each EC number, such as the correspond-
ing gene name or probe ID, and using a simple syntax these
may even be displayed as web links, turning metaSHARK into
a dynamic interface to other online databases. An example of
such an application can be found on the website, where
we provide links to the available PlasmoDB and PlasmoCyc
annotations for P.falciparum enzymes.
Case study: coenzyme A biosynthesis in
P.falciparum and E.tenella
Coenzyme A is an enzyme cofactor that is essential to all
organisms, taking part in many metabolic pathways, including
fatty acid synthesis and degradation, pyruvate oxidation and
glyceridesynthesis.The biosyntheticpathway forcoenzyme A
is shown in Figure 6. The full pathway (from 3-methyl-2-
oxobutanoate) is present in bacteria, plants and fungi,
but animals lack the initial steps and are dependent on food
and intestinal bacteria for a supply of pantothenate, a B-group
vitamin and coenzyme A precursor (25). We will use
coenzyme A biosynthesis as an example to show how
Figure 5. The metaSHARK web interface (http://bioinformatics.leeds.ac.uk/shark/) includes an applet, SHARKview, for the navigation and visualization of
metabolic networks. Links to KEGG (6) and PRIAM (11) provide further information about the network and sequence data used.
Nucleic Acids Research, 2005, Vol. 33, No. 4 1405metaSHARK can be used to examine the evidence for the
presence of a particular metabolic pathway in a sequenced
organism.
The nutritional requirements of P.falciparum have been
studied in some detail during the development of media for
continuous in vitro cultivation (26), during which it has
become evident that the intraerythrocytic stages are dependent
on the host for a number of essential nutrients. Modiﬁcations
induced in the erythrocyte membrane by the parasite introduce
new permeation pathways that allow it to obtain certain
micronutrients that are not ordinarily present in the red
blood cell (27,28). Pantothenic acid is one such essential
nutrient, which is required in the external medium for growth
of P.falciparum (26). In initial studies of coenzyme A require-
ments in Plasmodium lophurae grown in duck erythrocytes,
Bennett and Trager (29) suggested that this parasite lacks the
necessary enzymes for coenzyme A synthesis and must, there-
fore, rely on the enzymes already present in the host cell to
convert pantothenate to coenzyme A, which it then absorbs
from the cytosol. However, recent experiments with
P.falciparum in human erythrocytes by Saliba et al. (30)
reached markedly different conclusions. Parasitized erythro-
cytes were observed to rapidly take up pantothenate from the
extracellular medium, while uninfected cells exhibited negli-
gible uptake. The parasites were shown to have the ability to
absorb pantothenate and phosphorylate it, indicating the pres-
ence of a pantothenate kinase within the parasite. This parasite
pantothenate kinase activity was more than 10 times greater
than that observed in the host cell cytosol, indicating that the
P.falciparum genome must contain a gene encoding pan-
tothenate kinase, and presumably also contains genes for
the other enzymes necessary for coenzyme A synthesis
from pantothenate. In a subsequent study, Saliba and Kirk
(31) described a novel H
+-coupled pantothenate transporter
within the parasite cell membrane. This system for pantothen-
ate uptake is signiﬁcantly different from the mammalian
Na
+:pantothenate symporter, and as such may make a suitable
target for the development of new anti-malarial drugs. It will,
therefore, be important to characterize the parasite’s pathway
for pantothenate metabolism in more detail.
Table 3 shows the available annotation from PlasmoCyc
for coenzyme A biosynthesis, alongside the results from
the SHARKhunt search with an E-value cut-off of 10
 10.
Although PlasmoCyc shows only the ﬁnal enzyme in the path-
way, dephospho-CoA kinase (EC 2.7.1.24), SHARKhunt also
found good evidence for pantothenate kinase (EC 2.7.1.33),
phosphopantothenate-cysteine ligase (EC 6.3.2.5) and phos-
phopantothenoylcysteine decarboxylase (EC 4.1.1.36), the
ﬁrst three steps of the pathway from pantothenate to coenzyme
A. In a recent study of the evolution of coenzyme A bio-
synthesis, Genschel (32) also predicted these four enzymatic
functions using BLAST searches against the annotated
polypeptides from the P.falciparum annotation, and surmised
that P.falciparum,likeanimals,isable tosynthesize coenzyme
A from exogenous pantothenate. The only enzyme in this
pathway that was not convincingly detected by Genschel
was phosphopantetheine adenylyltransferase (EC 2.7.7.3),
although a candidate gene (PF07_0018) was detected using
PSI-BLAST at an E-value of 10
 6. The same candidate was
also detected by the SHARKhunt search of genomic DNA
with an E-value of 3.0 · 10
 6.
Figure 6. A SHARKview visualization of the coenzyme A biosynthesis
pathway. For an explanation of the symbols used, see legend to Figure 4.
Enzymes are labelled by their EC numbers: 2.1.2.11, 3-methyl-2-
oxobutanoate hydroxymethyltransferase; 1.1.1.169, 2-dehydropantoate 2-
reductase; 4.1.1.11, aspartate 1-decarboxylase; 6.3.2.1, pantoate-beta-alanine
ligase; 2.7.1.33, pantothenate kinase; 6.3.2.5, phosphopantothenate-cysteine
ligase; 4.1.1.36, phosphopantothenoylcysteine decarboxylase; 2.7.7.3,
pantetheine-phosphate adenylyltransferase; and 2.7.1.24, dephospho-CoA
kinase. Note that pool metabolites are neglected in this figure.
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known about the nutritional requirements of Eimeria spp.
Biochemical experiments are difﬁcult to carry out, owing to
the limited amount of pure material obtainable from either cell
culture or parasites grown in live hosts. In studies carried out
using vitamin-deﬁcient diets for Eimeria-infected chicks, Pra-
sad (33) demonstrated that neither E.tenella nor E.acervulina
required pantothenic acid in the chick diet for sustained
infections. In follow-up work, Warren (34) came to the
same conclusions, but observed that a chick diet containing
calcium pantothenate had the effect of increasing oocyst out-
put in E.tenella infections. However, a negative result using
the ‘deﬁcient diet’ technique does not necessarily imply that
the omitted nutrient is not required by the parasite, since it
might be synthesized by the host or by its gut ﬂora. Later in
vitro experiments by Doran and Augustine (35) with E.tenella
grown in chicken kidney cells showed that the omission of
pantothenate from the growth medium produced 89% as many
parasites as the control medium after two generations.
Table 3 shows the results obtained by PRIAM on all ORFs
over 50 amino acids alongside the SHARKhunt results,
both at an E-value cut-off of 10
 10. The ORF-based searches
have detected only pantothenate kinase (EC 2.7.1.33) and
dephospho-CoA kinase (EC 2.7.1.24), so would seem to sup-
port the conclusion that E.tenella, like P.falciparum, depends
on the host for a source of pantothenate. However, the results
obtained using SHARKhunt show very strong evidence for
the presence of the full coenzyme A biosynthesis pathway
from 3-methyl-2-oxobutanoate. Three enzymes upstream of
pantothenate (3-methyl-2-oxobutanoate hydroxymethyl-
transferase, EC 2.1.2.11; 2-dehydropantoate 2-reductase, EC
1.1.1.169; and pantoate-beta-alanine ligase, EC 6.3.2.1) were
detected, along with both enzymes found by PRIAM, a
phosphopantothenate-cysteine ligase (EC 6.3.2.5) and a phos-
phopantothenolycysteine decarboxylase (EC 4.1.1.36). Of the
missing two enzymes that were not detected at this cut-off,
one, phosphopantetheine adenylyltransferase (EC 2.7.7.3)
had a convincing candidate hit at E-value 2.7 · 10
 5.
No convincing candidate hits were found for aspartate
1-decarboxylase (EC 4.1.1.11). Indeed, genes encoding this
enzymatic function remain elusive in many archaeal, fungal
and bacterial genomes (32).
The experimental evidence outlined above is compat-
ible with the conclusion that E.tenella is able to synthesize
coenzyme A from 3-methyl-2-oxobutanoate. The presence
of a pantothenate biosynthesis pathway encoded within the
genome would not conﬂict with the experimentally observed
increase in the rate of parasite growth on adding calcium
pantothenate to the chick diet (34) or cell culture growth
medium (35). It is likely that supplementation of pantothenate
would increase growth even if the basal synthetic pathway
were active. Alternatively, it remains possible that the
enzymes for pantothenate synthesis are present in the genome
but are expressed at other stages in the life cycle.
In summary, the SHARKhunt search method was success-
ful in detecting the experimentally demonstrated but as yet
unannotated pantothenate to coenzyme A pathway encoded
in the P.falciparum genome. However, the SHARKhunt
results for the E.tenella genome show strong evidence for
the presence of genes coding for the entire bacterial/plant/
fungal coenzyme A biosynthetic pathway. The same conclu-
sion might not have been reached with a study of E.tenella
ORFs using the PRIAM software, which failed to detect any
enzymes upstream of pantothenate at an equivalent E-value
cut-off.
The evidence from any form of sequence analysis will
always require experimental validation to demonstrate that
the genes involved are expressed at a particular life stage
and truly perform the roles predicted for them. Nevertheless,
this case study is an excellent example of how metaSHARK
can be used to make concrete predictions of the metabolic
pathways encoded by unannotated genomic sequences and
hence guide experimental studies.
CONCLUSION
By working only with genomic DNA, metaSHARK offers an
improved level of ﬂexibility and accuracy over existing soft-
ware for automated enzyme annotation. In this work, we have
shown the validity of the SHARKhunt automated annotation
protocol by analysis of the genome of P.falciparum, then gone
on to demonstrate its usefulness by deriving new knowledge
of metabolic pathways within the unannotated genome
Table 3. Results of searches for enzymes involved in coenzyme A biosynthesis within the P.falciparum and E.tenella genomes
Enzyme P.falciparum E.tenella
PlasmoCyc-ANN
(human reannotation)
SHARKhunt
(E-value < 10
 10)
PRIAM
(E-value < 10
 10)
SHARKhunt
(E-value < 10
 10)
Pantothenate 2.1.2.11  
biosynthesis 1.1.1.169  
4.1.1.11
6.3.2.1  
Pantothenate 2.7.1.33    
metabolism 6.3.2.5   
4.1.1.36   
2.7.7.3
2.7.1.24       
A black circle indicates that the enzyme was found using the specified method. Enzymes are labelled by EC number, see legend to Figure 6 for full names. For
P.falciparum, The PlasmoCyc-ANN human reannotation (18) is compared with the SHARKhunt results at an E-value cut-off of 10
 10. No annotation is currently
availableforE.tenella,sowecomparethePRIAManalysisofallORFsof50aminoacidsorlongerwiththeSHARKhuntresultsusingtherawgenomicDNAsequence,
both taken at an E-value cut-off of 10
 10.
Nucleic Acids Research, 2005, Vol. 33, No. 4 1407of E.tenella. We have also introduced a powerful and intuitive
pathway navigation and visualization tool in the form of the
SHARKview applet. We believe that metaSHARK will be a
particularly valuable tool for the study of organisms that are
difﬁcult to manipulate in the laboratory, and also for the many
organisms for which low-coverage genomic DNA sequences
are becoming available. The SHARKhunt software is avail-
able to download at http://bioinformatics.leeds.ac.uk/shark/.
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